Literature DB >> 3318724

Effect of oestrogen treatment on clinical and laboratory manifestations of rheumatoid arthritis.

J W Bijlsma1, O Huber-Bruning, J H Thijssen.   

Abstract

The effect of administration of 12.5 micrograms ethinyloestradiol to 10 female patients with active rheumatoid arthritis was investigated in a prospective double blind crossover study. Some improvement during oestrogen treatment was found in 30 m walking time, haemoglobin concentration, and thrombocytosis. Erythrocyte sedimentation rate (ESR) and C reactive protein (CRP) deteriorated in both periods, but less in the oestrogen period. Grip strength improved during both periods. The number of swollen joints decreased, whereas the joint tenderness score increased during the oestrogen period.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3318724      PMCID: PMC1003387          DOI: 10.1136/ard.46.10.777

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

1.  NORETHYNODREL WITH MESTRANOL IN TREATMENT OF RHEUMATOID ARTHRITIS.

Authors:  M GILBERT; J ROTSTEIN; C CUNNINGHAM; I ESTRIN; A DAVIDSON; G PINCUS
Journal:  JAMA       Date:  1964-10-19       Impact factor: 56.272

2.  Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

Authors:  D M Ritchie; J A Boyle; J M McInnes; M K Jasani; T G Dalakos; P Grieveson; W W Buchanan
Journal:  Q J Med       Date:  1968-07

3.  Noncontraceptive hormones and rheumatoid arthritis in perimenopausal and postmenopausal women.

Authors:  J P Vandenbroucke; J C Witteman; H A Valkenburg; J W Boersma; A Cats; J J Festen; A P Hartman; O Huber-Bruning; J J Rasker; J Weber
Journal:  JAMA       Date:  1986-03-14       Impact factor: 56.272

4.  Sex steroids and the rheumatic diseases.

Authors:  R G Lahita
Journal:  Arthritis Rheum       Date:  1985-02

Review 5.  Regulation of the immune system by sex steroids.

Authors:  C J Grossman
Journal:  Endocr Rev       Date:  1984       Impact factor: 19.871

6.  The influence of hormonal contraceptives on sex hormone binding globulin (SHBG) capacity.

Authors:  E van Kammen; J H Thijssen; B Rademaker; F Schwarz
Journal:  Contraception       Date:  1975-01       Impact factor: 3.375

7.  The influence of pituitary hormones on adjuvant arthritis.

Authors:  I Berczi; E Nagy; S L Asa; K Kovacs
Journal:  Arthritis Rheum       Date:  1984-06

8.  Hormonal modulation in systemic lupus erythematosus. Preliminary clinical and hormonal results with cyproterone acetate.

Authors:  P Jungers; F Kuttenn; F Liote; C Pelissier; N Athea; M C Laurent; J Viriot; M Dougados; J F Bach
Journal:  Arthritis Rheum       Date:  1985-11

9.  Effect of pregnancy and hormonal changes on the activity of rheumatoid arthritis.

Authors:  M Ostensen; B Aune; G Husby
Journal:  Scand J Rheumatol       Date:  1983       Impact factor: 3.641

10.  Relation of menstrual cycle phase to symptoms of rheumatoid arthritis.

Authors:  N S Latman
Journal:  Am J Med       Date:  1983-06       Impact factor: 4.965

View more
  13 in total

Review 1.  Sexual dimorphism of RA manifestations: genes, hormones and behavior.

Authors:  William J Kovacs; Nancy J Olsen
Journal:  Nat Rev Rheumatol       Date:  2011-02-01       Impact factor: 20.543

Review 2.  Oral contraception and its possible protection against rheumatoid arthritis.

Authors:  J M Hazes; D van Zeben
Journal:  Ann Rheum Dis       Date:  1991-02       Impact factor: 19.103

3.  Hormonal contraception and the development of autoimmunity: A review of the literature.

Authors:  William V Williams
Journal:  Linacre Q       Date:  2017-08-18

4.  Intra-articular steroids: confounder of clinical trials.

Authors:  H G Taylor; P D Fowler; M J David; P T Dawes
Journal:  Clin Rheumatol       Date:  1991-03       Impact factor: 2.980

5.  Pregnancy and oral contraceptive use do not significantly influence outcome in long term rheumatoid arthritis.

Authors:  K W Drossaers-Bakker; A H Zwinderman; D van Zeben; F C Breedveld; J M W Hazes
Journal:  Ann Rheum Dis       Date:  2002-05       Impact factor: 19.103

6.  Effects of hormone replacement therapy in rheumatoid arthritis: a double blind placebo-controlled study.

Authors:  A G MacDonald; E A Murphy; H A Capell; U Z Bankowska; S H Ralston
Journal:  Ann Rheum Dis       Date:  1994-01       Impact factor: 19.103

7.  Adjuvant oestrogen therapy does not improve disease activity in postmenopausal patients with rheumatoid arthritis.

Authors:  H R van den Brink; A A van Everdingen; M J van Wijk; J W Jacobs; J W Bijlsma
Journal:  Ann Rheum Dis       Date:  1993-12       Impact factor: 19.103

8.  A randomised controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis.

Authors:  G M Hall; M Daniels; E C Huskisson; T D Spector
Journal:  Ann Rheum Dis       Date:  1994-02       Impact factor: 19.103

9.  Autoimmune disease during pregnancy and the microchimerism legacy of pregnancy.

Authors:  Kristina M Adams Waldorf; J Lee Nelson
Journal:  Immunol Invest       Date:  2008       Impact factor: 3.657

10.  Effects of postmenopausal hormone therapy on rheumatoid arthritis: the women's health initiative randomized controlled trials.

Authors:  Brian Walitt; Mary Pettinger; Arthur Weinstein; James Katz; James Torner; Mary Chester Wasko; Barbara V Howard
Journal:  Arthritis Rheum       Date:  2008-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.